fbpx

LATEST NEWS

Roles Split When Stress Makes Attorney Unreliable

8th September, 2016 By Arman Khosravi

Appointing an attorney under a Lasting Power of Attorney (LPA) is normally a sensible precaution. The procedure allows one's financial affairs (and, if required, matters relating to health and welfare) to be entrusted to others if you are unable to manage them yourself. The procedure is that, at the appropriate time, the person named registers the LPA at the Office of the Public Guardian (OPG). The attorney then carries out the role under the supervision of the OPG, which, in normal circumstances, uses a very 'light touch'. The choice of attorney...

Roles Split When Stress Makes Attorney Unreliable

8th September, 2016 By Arman Khosravi

Appointing an attorney under a Lasting Power of Attorney (LPA) is normally a sensible precaution. The procedure allows one's financial affairs (and, if required, matters relating to health and welfare) to be entrusted to others if you are unable to manage them yourself. The procedure is that, at the appropriate time, the person named registers the LPA at the Office of the Public Guardian (OPG). The attorney then carries out the role under the supervision of the OPG, which, in normal circumstances, uses a very 'light touch'. The choice of attorney...

Community Rejects Eyesore Wind Turbines

5th September, 2016 By Arman Khosravi

Wind farms can be seen for miles around and their visual impact on nearby heritage assets can frequently prove decisive in planning terms. That was certainly so in one case in which proposals for five wind turbines within sight of a listed church were scotched by the High Court. The church stood in a village which had been abandoned for more than 20 years following a catastrophic explosion at a nearby oil refinery. Although no longer serving a parish, the church was carefully maintained by a charity and was Grade...

Exceptional Cases Justify Experimental Care

2nd September, 2016 By Arman Khosravi

In a unique decision, which will give hope to people who have family members being denied experimental treatments by the NHS on costs grounds, the NHS has been ordered to provide a pioneering new drug to a teenager whose bright future was threatened by a rare medical condition. Although the treatment would cost up to £13,000 a year, and had not yet been approved for prescription on the NHS, the High Court ruled that it was an exceptional case that deserved funding. The 17-year-old girl suffers from cataplexy, a condition...